Analysing Sepsis Management Part II: Treatments
Recent developments in Sepsis Treatment focused towards antibiotics, inhibitors, antibodies, peptides, recombinant proteins, antibacterial, antifungal, antivirals, vaccines, and probiotics
30-Nov-2020
Global
Technology Research
D9A0-01-00-00-00
HC03358-GL-TR_24988
Sepsis is a life-threatening condition caused by overactivation of host immune system upon infections which may lead to organ failure and potentially death. World Health Organization designates sepsis as a global public health priority. Several studies conducted to understand the molecular basis of sepsis, septic shock, and organ failure. Despite extensive preclinical and clinical studies conducted over the past few decades, no significant improvement has observed in sepsis management. Lack of effective therapeutics raises the question about our understanding of sepsis pathophysiology. Another challenge comes with the heterogeneous nature of sepsis which depends on several factors, such as the pathogen causing infection and age, genetic make-up, existing medical condition, and lifestyle of the person. A further challenge comes with a measurement of the success of novel therapeutics.
This research study begins with highlighting the current status of sepsis treatment, such as antibiotics used with different kinds of pathogens along with antifungal and antiviral drugs used to treat infections; and also talks about the importance of fluid resuscitation and oxygen therapy in severe sepsis. A brief introduction to the course of sepsis development, the most important pathogen involved in sepsis and commonly affected body sites and associated mortality rates have discussed.
This study highlights some of the most important aspects considered to improve the current understanding and underlying mechanisms of sepsis, importance of preclinical and clinical studies, integration of sepsis specific biomarker in therapeutics, detecting biological signals and gene expression levels and designing novel interventions such as immunomodulatory and personalized approaches. Moreover, this study covers new sepsis treatment approaches such as phage therapy, cellular immunotherapy, antibody therapeutics, recombinant protein therapeutics, peptide therapeutics, microbial therapeutics, and vaccines as well as newly designed receptor blocker, receptor inhibitors, agonist, and alkaloids. A short introduction to clinical updates and patent landscape for sepsis therapeutics has provided. The study concludes with an emphasis on adopting new technologies to develop our understanding of sepsis that will help design breakthrough therapeutics.
1.1 THE STRATEGIC IMPERATIVE 8™
1.2 THE STRATEGIC IMPERATIVE 8™
1.3 THE IMPACT OF THE TOP THREE STRATEGIC IMPERATIVES ON SEPSIS THERAPEUTICS INDUSTRY
1.4 ABOUT THE GROWTH PIPELINE ENGINE™
1.5 GROWTH OPPORTUNITIES FUEL THE GROWTH PIPELINE ENGINE™
2.1 RESEARCH SCOPE: SEPSIS THERAPEUTICS
2.2 ANALYSIS FRAMEWORK: FROST & SULLIVAN CORE VALUE
2.3 Research Methodology: Five Steps Toward Success
2.4 Key Findings of novel Sepsis therapeutics
3.1 Research Scope: Current Status and Challenges of Sepsis Therapeutics
3.2 Therapeutic strategies covered
3.3 Pathogenesis of Sepsis
3.4 Common bacteria and body sites involved in sepsis and associated mortality rates
4.1 Therapies for sepsis and septic shock management
4.2 Sepsis Treatment for antibiotic resistant bacteria
4.3 Antifungals treatment for sepsis
4.4 Treatment of viral sepsis
5.1 Advances in sepsis and septic shock therapeutics
5.2 Phage Therapy for severe sepsis
5.3 Cellular Immunotherapy for sepsis
5.4 Antibody-based immunotherapy for sepsis
5.5 Protein therapeutics for sepsis
5.6 Peptide Therapeutics for sepsis
5.7 Vaccines for sepsis
5.8 Novel receptor blocker and probiotic for sepsis treatment
5.9 Alkaloids and agonist for sepsis treatment
6.1 Interventions Used for Sepsis Management
6.2 Clinical Landscape for Sepsis Management
6.3 Phase 3 Clinical Trials for Sepsis Management
6.4 Phase 3 Clinical Trials for Biological therapeutics for Sepsis
6.5 Drugs in Phase 3 Clinical Trials for Sepsis Management
7.1 Published patent count for sepsis is witnessing steady growth
8.1 GROWTH OPPORTUNITY: NEW KNOWLEDGE AND TECHNOLOGIES ARE NEEDED TO BETTER UNDERSTAND SEPSIS, 2020
8.2 GROWTH OPPORTUNITY: NEW KNOWLEDGE AND TECHNOLOGIES ARE NEEDED TO BETTER UNDERSTAND SEPSIS, 2020
9.1 Industry Interactions
9.2 Industry Interactions
YOUR NEXT STEPS
WHY FROST, WHY NOW?
LEGAL DISCLAIMER
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
17 Nov 2026 | Global | Frost Radar
Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026
Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...
16 Nov 2026 | North America | Frost Radar
Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026
This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
02 Nov 2026 | Global | Market Research
Continuous Glucose Monitoring Market, Global, 2026
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...
28 Oct 2026 | Global | Frost Radar
Frost Radar™: Health Monitoring Wearable Solutions, 2026
The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.